Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of pain in elderly patients receiving infusion of zoledronic acid for bone metastasis: a single-institution report.
Addeo R, Nocera V, Faiola V, Vincenzi B, Ferraro G, Montella L, Guarrasi R, Rossi E, Cennamo G, Tonini G, Capasso E, Santini D, Caraglia M, Del Prete S. Addeo R, et al. Among authors: guarrasi r. Support Care Cancer. 2008 Feb;16(2):209-14. doi: 10.1007/s00520-007-0315-y. Epub 2007 Aug 14. Support Care Cancer. 2008. PMID: 17701225
Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women > or = 65 years of age.
Addeo R, Faiola V, Guarrasi R, Montella L, Vincenzi B, Capasso E, Cennamo G, Rotundo MS, Tagliaferri P, Caraglia M, Del Prete S. Addeo R, et al. Among authors: guarrasi r. Cancer Chemother Pharmacol. 2008 Jul;62(2):285-92. doi: 10.1007/s00280-007-0605-6. Epub 2007 Oct 9. Cancer Chemother Pharmacol. 2008. PMID: 17922275 Clinical Trial.
Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series.
Montella L, Addeo R, Palmieri G, Caraglia M, Cennamo G, Vincenzi B, Guarrasi R, Mamone R, Faiola V, Frega N, Capasso E, Maiorino L, Leopardo D, Pizza C, Montesarchio V, Del Prete S. Montella L, et al. Among authors: guarrasi r. Cancer Chemother Pharmacol. 2010 May;65(6):1137-43. doi: 10.1007/s00280-009-1122-6. Epub 2009 Sep 16. Cancer Chemother Pharmacol. 2010. PMID: 19760218 Clinical Trial.
Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance.
Addeo R, Caraglia M, Bellini S, Abbruzzese A, Vincenzi B, Montella L, Miragliuolo A, Guarrasi R, Lanna M, Cennamo G, Faiola V, Del Prete S. Addeo R, et al. Among authors: guarrasi r. J Clin Oncol. 2010 Feb 1;28(4):543-8. doi: 10.1200/JCO.2008.20.8199. Epub 2009 Oct 19. J Clin Oncol. 2010. PMID: 19841330 Clinical Trial.
Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study.
Prete SD, Montella L, Caraglia M, Maiorino L, Cennamo G, Montesarchio V, Piai G, Febbraro A, Tarantino L, Capasso E, Palmieri G, Guarrasi R, Bianco M, Mamone R, Savastano C, Pisano A, Vincenzi B, Sabia A, D'Agostino A, Faiola V, Addeo R. Prete SD, et al. Among authors: guarrasi r. Cancer Chemother Pharmacol. 2010 Oct;66(5):837-44. doi: 10.1007/s00280-009-1226-z. Epub 2009 Dec 30. Cancer Chemother Pharmacol. 2010. PMID: 20041325 Clinical Trial.
22 results